DAVID MAPES: Open Payments
NPI 1427428010 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,479 in 118 payments from 14 companies in 2025. Trend: 2023 $2,301 · 2024 $1,301 · 2025 $6,479
Travel & lodging: $2,410Food & beverage: $2,203Consulting: $1,800Education: $66
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 28 | $4,741 |
| ABBVIE INC. | 18 | $319 |
| Incyte Corporation | 9 | $286 |
| Janssen Biotech, Inc. | 20 | $257 |
| UCB, Inc. | 6 | $163 |
| LEO Pharma Inc. | 10 | $156 |
| GENZYME CORPORATION | 5 | $140 |
| E.R. Squibb & Sons, L.L.C. | 9 | $139 |
| Amgen Inc. | 5 | $81 |
| Novartis Pharmaceuticals Corporation | 2 | $67 |
Products named: Zoryve, OPZELURA, TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, Sotyktu, RINVOQ.
Industry payments across CA — which companies pay providers there.
